LENZ Therapeutics, Inc. - Common Stock

Share · US52635N1037 · LENZ (XNAS)

Overview

Analyst Grade Summary

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

No Price

16.12.2025 22:26

Current Prices from LENZ Therapeutics, Inc. - Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	LENZ	USD	16.12.2025 22:26	17,00 USD	-0,08 USD -0,47 %

Share Float & Liquidity

Free Float 100,92 %

Shares Float 28,17 M

Shares Outstanding 27,91 M

Company Profile for LENZ Therapeutics, Inc. - Common Stock Share

LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.

Get up to date insights from finAgent about LENZ Therapeutics, Inc. - Common Stock

Company Data

Name LENZ Therapeutics, Inc. - Common Stock

Company LENZ Therapeutics, Inc.

Symbol LENZ

Website https://www.lenz-tx.com

Primary Exchange

NASDAQ

ISIN US52635N1037

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Evert B. Schimmelpennink

Market Capitalization 466 Mio

Country United States of America

Currency USD

Employees 0,0 T

Address 445 Marine View Avenue, 92014 Solana Beach

IPO Date 2024-03-22

Dividends from 'LENZ Therapeutics, Inc. - Common Stock'

Ex-Date	Dividend per Share
22.03.2024	0,15 USD

ID Changes

Date	From	To
22.03.2024	GRPH	LENZ

Ticker Symbols

Name	Symbol
NASDAQ	LENZ

More Shares

Investors who hold LENZ Therapeutics, Inc. - Common Stock also have the following shares in their portfolio:

Brand 24 S.A. Share

LEASYS 24/29 MTN Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog